心肌病临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 心肌病（国际通用名 cardiomyopathy）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖肥厚型心肌病、扩张型心肌病等说法。

正在招募的心肌病新药试验

• Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer

  不适用招募中中国NCT06818149

• NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis

  不适用招募中意大利NCT06251778

• Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes

  不适用招募中意大利NCT07382128

• Clinical Study for AL-CM

  不适用招募中中国NCT04924998

• Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy

  不适用招募中中国NCT07293338

• Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

  不适用招募中美国法国德国意大利NCT06311708

• Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease

  不适用招募中澳大利亚NCT06360939

• Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia

  I 期招募中美国NCT05302271

• Clinical Efficacy and Safety of Left Bundle Branch Area Pacing Using Quantitative Guidance of Multimodal Data in the Treatment of Heart Failure

  不适用招募中中国NCT07814612

• High Fat Diet for Cardiac Metabolic Reprogramming

  不适用招募中法国意大利Romania西班牙NCT06747429

• Quantitative Cardiac Parametric Mapping

  不适用招募中美国NCT02855554

• Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy

  II 期 / III 期招募中DenmarkNCT06128980